BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1907754)

  • 1. Macrophage activation and resistance to Trypanosoma cruzi infection.
    Russo N; Starobinas N
    Res Immunol; 1991 Feb; 142(2):144-6. PubMed ID: 1907754
    [No Abstract]   [Full Text] [Related]  

  • 2. CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi.
    Martins GA; Tadokoro CE; Silva RB; Silva JS; Rizzo LV
    J Immunol; 2004 Apr; 172(8):4893-901. PubMed ID: 15067068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptible mice present higher macrophage activation than resistant mice during infections with myotropic strains of Trypanosoma cruzi.
    Russo M; Starobinas N; Ribeiro-Dos-Santos R; Minoprio P; Eisen H; Hontebeyrie-Joskowicz M
    Parasite Immunol; 1989 Jul; 11(4):385-95. PubMed ID: 2528710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo macrophage function in experimental infection with Trypanosoma cruzi subpopulations.
    Celentano AM; González Cappa SM
    Acta Trop; 1993 Nov; 55(3):171-80. PubMed ID: 7903839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency distribution of Trypanosoma cruzi in macrophages from resistant and susceptible strains of mice.
    Pécora IL; dos Reis GA; Barcinski MA; Dorigo DD
    Experientia; 1980 Aug; 36(8):942-4. PubMed ID: 6777186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection.
    Leavey JK; Tarleton RL
    J Immunol; 2003 Mar; 170(5):2264-8. PubMed ID: 12594245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi: flow cytometric analysis of lymphocyte subsets in susceptible and protected C3H/He mice.
    Powell MR; Rowland EC; Sidner RA
    Exp Parasitol; 1991 Aug; 73(2):197-202. PubMed ID: 1679718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: T-cell-dependent mechanisms of resistance during chronic infection.
    Rottenberg ME; Cardoni RL; Sinagra A; Riarte A; Rodriguez Nantes I; Lauricella M; Segura EL
    Exp Parasitol; 1991 Aug; 73(2):127-36. PubMed ID: 1909649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection.
    Sun J; Tarleton RL
    Am J Trop Med Hyg; 1993 Feb; 48(2):161-9. PubMed ID: 8447518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T-cell subpopulations in experimental Chagas' disease.
    Tarleton RL
    Res Immunol; 1991 Feb; 142(2):130-3. PubMed ID: 1678199
    [No Abstract]   [Full Text] [Related]  

  • 11. Trypanosoma cruzi: ability of T-cell-enriched and -depleted lymphocyte populations to passively protect mice.
    Trischmann TM; Bloom BR
    Exp Parasitol; 1980 Apr; 49(2):225-32. PubMed ID: 6767621
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIF-driven activation of macrophages induces killing of intracellular Trypanosoma cruzi dependent on endogenous production of tumor necrosis factor, nitric oxide and reactive oxygen species.
    Cutrullis RA; Petray PB; Corral RS
    Immunobiology; 2017 Feb; 222(2):423-431. PubMed ID: 27591076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi: role of the immune response in the natural resistance of inbred strains of mice.
    Trischmann T; Tanowitz H; Wittner M; Bloom B
    Exp Parasitol; 1978 Aug; 45(2):160-8. PubMed ID: 210036
    [No Abstract]   [Full Text] [Related]  

  • 15. Trypanosoma cruzi: early parasite proliferation and host resistance in inbred strains of mice.
    Trischmann TM
    Exp Parasitol; 1986 Oct; 62(2):194-201. PubMed ID: 2427355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi.
    Savino W; Villa-Verde DM; Mendes-da-Cruz DA; Silva-Monteiro E; Perez AR; Aoki Mdel P; Bottasso O; Guiñazú N; Silva-Barbosa SD; Gea S
    Cytokine Growth Factor Rev; 2007; 18(1-2):107-24. PubMed ID: 17339126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian Target of Rapamycin Inhibition in
    Rojas Márquez JD; Ana Y; Baigorrí RE; Stempin CC; Cerban FM
    Front Immunol; 2018; 9():313. PubMed ID: 29515594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation and histopathological findings in Calomys callosus and Swiss mice infected with several strains of Trypanosoma cruzi.
    Borges MM; De Andrade SG; Pilatti CG; do Prado Júnior JC; Kloetzel JK
    Mem Inst Oswaldo Cruz; 1992; 87(4):493-502. PubMed ID: 1343663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
    Silva JS; Twardzik DR; Reed SG
    J Exp Med; 1991 Sep; 174(3):539-45. PubMed ID: 1908509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.